ConductScience.org, home

Paper2159385

Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site.

Baniahmad A and 3 others. Cell, 1990. Cited by 452 papers, by iCite.

Cite this record

ConductScience Library. Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. Papers, record 2159385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2159385

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site.
PubMed
Journal
Cell
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
452
iCite
Relative citation ratio, by iCite
7.5
iCite
Revised in PubMed
2019-07-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baniahmad AA
2Steiner CC
3Köhne ACA C
4Renkawitz RR

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA-Binding ProteinsMajor topic
Genes, RegulatorMajor topic
MuramidaseMajor topic
Proto-Oncogene ProteinsMajor topic
Receptors, Thyroid HormoneMajor topic
Animals
Base Sequence
Binding Sites
Cell Line
Cell Nucleus
Chick Embryo
Chickens
Chromosome Deletion
Enhancer Elements, Genetic
Macrophages
Molecular Sequence Data
Oligonucleotide Probes
Plasmids
Transfection

Source PubMed

Download CSV of topics

Cited by168

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 452 citations.

PMIDTitleJournalYearIn PapersSource
41739993Dysregulation of the PATZ1/CTCF Balance Silences ZBTB20 to Drive Melanoma Progression.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41739993PubMed
37337907Enhancers of the PAIR4 regulatory module promote distal VH gene recombination at the Igh locus.EMBO J2023https://conductscience.org/library/papers/37337907PubMed
36369346CTCF blocks antisense transcription initiation at divergent promoters.Nat Struct Mol Biol2022https://conductscience.org/library/papers/36369346PubMed
35993175CTCF shapes chromatin structure and gene expression in health and disease.EMBO Rep2022https://conductscience.org/library/papers/35993175PubMed
35806002TRα2-An Untuned Second Fiddle or Fine-Tuning Thyroid Hormone Action?Int J Mol Sci2022https://conductscience.org/library/papers/35806002PubMed
35518765Dityrosine suppresses the cytoprotective action of thyroid hormone T3 via inhibiting thyroid hormone receptor-mediated transcriptional activation.RSC Adv2020https://conductscience.org/library/papers/35518765PubMed
34828313Decoding the Equine Genome: Lessons from ENCODE.Genes (Basel)2021https://conductscience.org/library/papers/34828313PubMed
34502048The Role of Histone Deacetylase 3 Complex in Nuclear Hormone Receptor Action.Int J Mol Sci2021https://conductscience.org/library/papers/34502048PubMed
34414474Transcriptional enhancers and their communication with gene promoters.Cell Mol Life Sci2021https://conductscience.org/library/papers/34414474PubMed
34158481The combined action of CTCF and its testis-specific paralog BORIS is essential for spermatogenesis.Nat Commun2021https://conductscience.org/library/papers/34158481PubMed
33673494A Newly Assigned Role of CTCF in Cellular Response to Broken DNAs.Biomolecules2021https://conductscience.org/library/papers/33673494PubMed
33168819MiR-22, regulated by MeCP2, suppresses gastric cancer cell proliferation by inducing a deficiency in endogenous S-adenosylmethionine.Oncogenesis2020https://conductscience.org/library/papers/33168819PubMed
32775616An Artificial CTCF Peptide Triggers Efficient Therapeutic Efficacy in Ocular Melanoma.Mol Ther Oncolytics2020https://conductscience.org/library/papers/32775616PubMed
32503656CTCF loss mediates unique DNA hypermethylation landscapes in human cancers.Clin Epigenetics2020https://conductscience.org/library/papers/32503656PubMed
31945090Pan-cancer analysis of somatic mutations and epigenetic alterations in insulated neighbourhood boundaries.PLoS One2020https://conductscience.org/library/papers/31945090PubMed
31910870Clustered CTCF binding is an evolutionary mechanism to maintain topologically associating domains.Genome Biol2020https://conductscience.org/library/papers/31910870PubMed
31798605Mapping and Dynamics of Regulatory DNA in Maturing Arabidopsis thaliana Siliques.Front Plant Sci2019https://conductscience.org/library/papers/31798605PubMed
30674949Involvement of CTCF in transcription regulation of EGR1 at early G1 phase as an architecture factor.Sci Rep2019https://conductscience.org/library/papers/30674949PubMed
30390146Targeting CTCFL/BORIS for the immunotherapy of cancer.Cancer Immunol Immunother2018https://conductscience.org/library/papers/30390146PubMed
29437926CCCTC-Binding Factor Acts as a Heterochromatin Barrier on Herpes Simplex Viral Latent Chromatin and Contributes to Poised Latent Infection.mBio2018https://conductscience.org/library/papers/29437926PubMed

See all 168 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2159385

GET https://conductscience.org/api/papers/v1/2159385/cited_by?page=2